
OpinionCTVA
Corteva's selloff is ignoring its biggest rerating catalyst
A raised FY2026 outlook and an October 1 separation timetable are powerful catalysts that the 11.9% selloff has not reflected. CTVA is a contrarian buy-on-weakness setup, with execution risk—not the operating trend—the main obstacle.
Aug 10, 20262 MIN